Search for: "Kluwer IP Reporter" Results 181 - 200 of 409
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Sep 2016, 2:05 am by Brian Cordery
Moderator Prof Cesare Galli (IP Law Galli), and panellists Sarah Matheson (AIPPI Reporter General), Gordon Harris (Gowlings WLG (UK)), Francesca Giovanni (OSHA Liang (FR)) and Tobias Dolde (Noerr (DE)) debated various topics, including possible changes to substantive IP laws where they have been harmonised at EU level, the consequences on enforcement strategies, new opportunities which may arise and the consequences of Brexit on SPCs, patents, trade marks and design… [read post]
25 Apr 2016, 12:05 am by Pieter Callens
In a series of articles, Kluwer IP Law explains the upcoming changes and the consequences they have for patent practitioners. [read post]
8 Dec 2010, 2:20 am by Marie Louise
Bulgarian Patent Office (Kluwer Patent Blog) Canada: World AIDS Day brings calls for legislative caution, reform (IP Watch) EU: EMA publishes guidelines for biosimilar antibodies (Part I – Patent Docs), (Part II – Patent Docs) EU: AstraZeneca and Nycomed raid by EU antitrust officials (GenericsWeb) India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) India:… [read post]
15 Apr 2016, 9:46 am by Kluwer UPC News blogger
’ For regular updates on the UP system, subscribe to this blog and the free Kluwer IP Law Newsletter. [read post]
26 Sep 2011, 4:42 am by Marie Louise
(Kluwer Patent Blog) The pirates across Europe (IAM) IPKat threatens European and judicial serenity (IPKat) That dirty trick: The ECJ says “no! [read post]
7 Feb 2011, 2:58 am by Marie Louise
(Kluwer Patent Blog) Sweden Stockholm District Court costs decision – Centraction v. [read post]
24 Aug 2011, 12:33 am by Marie Louise
Intema Limited (Docket Report) US: Is claim construction the key to patent-eligibility of isolated DNA? [read post]
31 May 2011, 8:38 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Mar 2021, 10:23 am by Sophie Corke
This Kat is searching for IP newsWhat better way to relax and look forward to the week ahead than consuming the latest IP news and views? [read post]
12 Oct 2011, 3:46 am by Marie Louise
  General Australian Senate Committee issues recommendation on Gene Patenting Bill (Patent Docs) EU: Paediatrics and transitional periods: a reader writes (The SPC Blog) Indian generics Aurobindo Pharma Limited and MedChem join Medicines Patent Pool (Spicy IP) (IP Watch) (IPBiz) Italy: Generics can be sued in the courts of the pharmacies, says the Court of Turin (Kluwer Patent Blog) US: Appealing premarket disputes in the Device Center: Reform is needed (FDA Law Blog)… [read post]
8 Feb 2011, 10:51 pm by Marie Louise
General Nations begin signing protocol on biodiversity access and benefit-sharing (IP Watch) (IP tango) New biodiversity benefit-sharing protocol relies on national rules, experts say (IP Watch) Are patents a double-edged sword? [read post]
10 Mar 2023, 8:42 am by Kluwer Patent blogger
A spokesperson told Kluwer IP Law: ‘Once an agreement has been reached, the intention is first to inform the other member states of the outcome of the deliberations and to start negotiations among all member states in the competent body. [read post]
29 Nov 2010, 12:23 am by Kelly
(IP Factor) Trademark request for ‘Quality Management’ rejected as being laudatory (IP Factor) Fast Israel Patent Office search reports available for priority applications (IP Factor) Italy Preliminary technical assessment in Italian patent cases (Kluwer Patent Blog) Trademark battle prevails over political debate? [read post]
29 Jun 2018, 2:32 pm by Kluwer Patent blogger
For regular updates on the Unitary Patent and the Unified Patent Court, subscribe to this blog and the free Kluwer IP Law Newsletter. [read post]
16 Dec 2016, 1:51 pm by Kluwer UPC News blogger
For regular updates on the Unitary Patent and the Unified Patent Court, subscribe to this blog and the free Kluwer IP Law Newsletter. [read post]